You just read:

Orexigen Therapeutics Announces Commercialization and Distributorship Agreement with Valeant Canada for Contrave® (naltrexone HCl / bupropion HCl extended release)

News provided by

Orexigen Therapeutics, Inc.

Aug 30, 2016, 08:00 ET